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Osler-Weber-Rendu Disease
INTRODUCTION
Osler-Weber-Rendu disease (OWRD), also known
as hereditary hemorrhagic telangiectasia, is a familial
disease characterized by telangiectasia of the mucous
membranes and skin [1]. Patients with OWRD
frequently present with recurrent nasal or
gastrointestinal bleeding [1, 2]. The vascular
malformation (or angiodysplasia) may be widespread
throughout the body. Arteriovenous malformations
(AVM) have been described in the central nervous
system, lungs, liver, and urinary tract [1–7].
Intrahepatic vascular malformations frequently
present as shunting between hepatic arteries and
portal veins [4–8]. Shunts between portal and hepatic
veins have rarely been demonstrated in the liver [3,
4]. Although these portohepatic venous shunts
(PHVS) may be disclosed using ultrasound [9],
direct evidence of PHVS on ultrasound may not be
convincing. In this report, we demonstrate PHVS
using ultrasound-guided percutaneous transhepatic
portography with ultrasonic contrast agent (USCA)
injection.
TECHNIQUES AND CASE ILLUSTRATON
A 70-year-old man was admitted with the chief
complaints of abdominal fullness and two episodes
Received: April 18, 2003.   Accepted: June 9, 2003.
Department of Radiology and 1Division of Gastroenterology, Department of Internal Medicine, Taipei Veterans General
Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan.
Address correspondence and reprint requests to: Dr. Chui-Mei Tiu, Department of Radiology, Veterans General
Hospital-Taipei, 201, Shi-Pai Road, Section II, Taipei, Taiwan.
© 2003 Elsevier. All rights reserved.
Osler-Weber-Rendu Disease:
Transhepatic Portography Using Ultrasonic
Contrast Agents to Demonstrate
Intrahepatic Porto-systemic Shunts
Yi-Hong Chou, Hong-Jen Chiou, Chui-Mei Tiu, See-Ying Chiou, Chen-Chun Lin1 and Jaw-Ching Wu1
While shunts between portal and hepatic veins in Osler-Weber-Rendu disease have
rarely been demonstrated in the liver, these portohepatic venous shunts (PHVS) may
be revealed by ultrasound. However, direct evidence of PHVS on ultrasound may
not be convincing. In this report, we demonstrate PHVS using ultrasound-guided
percutaneous transhepatic portography with ultrasonic contrast agent (USCA) injection.
With this technique, the microbubble-based USCA was depicted to enter the hepatic
vein by way of the shunts and then flow into the inferior vena cava. The shunts
were confirmed by iodinated contrast venography via the same sheathed needle.
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of the passage of tarry stools in the last month. The
history was unremarkable except for occasional nose
bleeds. On physical examination, he had anemic
conjunctivae and telangiectases on the tongue, lips,
nasal septum, and bilateral turbinates. He had a
regular pulse with a grade 2/6 precordial systolic
murmur on auscultation. The vertical span of the
right hepatic lobe was about 15 cm on percussion,
indicating mild hepatomegaly. Other parts of the
abdomen were normal. Laboratory values were within
the normal range except for minimally elevated
alkaline phosphatase (220 IU/L) and alanine
aminotransferase (52 IU/L). Ultrasound study of the
upper abdomen to investigate the cause of
hepatomegaly disclosed a dilated common hepatic
artery (maximal diameter, 8.5 mm) and multiple
tortuous tubular structures representing vascular
channels in the right hepatic lobe. Careful ultrasound
tracing and color Doppler ultrasound evaluation of
the right lobe vessels suggested communication
between the right portal branches and the right
hepatic veins through these vascular channels (Fig.
1). Based on the clinical manifestations and
ultrasound findings in the liver, a diagnosis of OWRD
was made. The liver pathology was attributed to
intrahepatic PHVS. To verify the existence of
shunting, percutaneous transhepatic portography was
performed using percutaneous puncture of the right
portal branch with an 18-gauge Teflon-sheathed
needle (Fig. 2A). The soft sheath was retained in
the right portal branch for contrast injection.
Venography used manual injection of 10 mL
Levovist® (Schering, Berlin, Germany) at a
concentration of 200 mg/mL. Cloud-like contrast-
enhanced blood flow was demonstrated in the right
portal branch. Enhanced blood ran toward the right
hepatic vein and then to the inferior vena cava via
the communicating collateral venous channels (Fig.
2B). Subsequent iodinated venography (20 mL, 38%)
confirmed shunting (Fig. 3). The patient tolerated
the procedure well. After the Teflon sheath was
removed, local compression was applied to the
puncture site for 20 minutes, and bed rest in the
right decubitus position for 4 hours was
recommended. A diagnosis of hepatic angiodysplasia
with PHVS was confirmed based on the findings
of contrast-enhanced ultrasonic venography and
iodinated venography. The patient was therefore
treated conservatively for gastrointestinal bleeding
and has been doing well for 1 year.
Fig. 1. (A) Color Doppler ultrasound of the epigastric
region demonstrates a dilated hepatic artery (arrows).
(B) Ultrasound of the right lobe shows dilated vessels
in the region of segment 7 (arrows). (C) Color Doppler
ultrasound depicts a possible communication (arrowhead)
between a branch of the right portal vein (straight arrow)
and the right hepatic vein (curved arrow).
DISCUSSION
In OWRD, visceral organs are frequently involved
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membranes. Characteristic angiodysplastic lesions
may include the lungs, liver, spleen, pancreas,
gastrointestinal tract, and mesentery. Arterial
aneurysms and variable degrees of arteriovenous
fistula (AVF) may be an integral part of the
abnormality [5]. The basic abnormality in OWRD
is attributed to a disorder of the arteries and the
arteriolar-precapillary sphincters [6]. With loss of
the regulatory sphincter mechanism of the arteriolar-
capillary junction, arterial blood overflows into the
capillary and venules without restriction, which
subsequently causes small AVFs. If the hemodynamic
overload and high pressure persist, the involved
vessels will be dilated, elongated, tortuous, and even
coiled [5]. Angiographic manifestations of visceral
angiodysplasia correlate closely with these pathologic
findings. In the liver, diffuse small AVFs may emerge
[7], and direct macroscopic AVFs may coexist with
telangiectatic lesions in various stages of transition.
With progressive increase in the hemodynamic load,
marked ectasia, frank AVFs, and aneurysms may
affect both afferent and efferent vessels [6–8].
The cause of PHVS in patients with OWRD is
still unclear. PHVS has also been described in other
disease entities such as liver cirrhosis and Budd-
Chiari syndrome [9]. Liver cirrhosis has been
documented in association with OWRD; at least 20
cases of unexplained cirrhosis have been reported
[10–13]. Cirrhosis was attributed to telangiectases
or to ischemia and/or vascular malformation [11,
12]. Since our patient had no clinical or histo-
pathologic evidence of hepatic fibrosis, his PHVS
may be simply related to angiodysplasia involving
the portal vein.
The hepatic vasculature is best evaluated with
iodinated contrast angiography. Since the
development of cross-sectional imaging modalities
such as computed tomography (CT), ultrasound, and
magnetic resonance imaging (MRI), noninvasive
demonstration of the hepatic vasculature has been
made possible. These techniques, also referred to as
CT angiography, MR angiography, and ultrasonic
angiography in their state-of-the-art functions, have
been used in clinical studies of visceral vessels [14–
Fig. 2. Percutaneous transhepatic portography using
ultrasonic contrast agent (USCA). (A) Ultrasound-guided
percutaneous puncture of the right portal branch (arrow).
The needle tip is visible in the lumen of the portal branch
(arrowhead). (B) Immediately after USCA administration,
the initially echo-free vascular lumens are enhanced by
the microbubbles and become echogenic (arrows); the
right hepatic vein and inferior vena cava (arrowheads)
are also enhanced within 1 second.
Fig. 3. Iodinated venography via the right portal branch
demonstrates the dilated venous channels (arrows) in the
right hepatic lobe near the dome and the early opacified
right hepatic vein and inferior vena cava (arrowheads).
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19]. Among these, ultrasound in conjunction with
various Doppler techniques is the most convenient
method to evaluate hepatic vasculature [19]. Color
Doppler ultrasound findings of OWRD include large
feeding arteries, prominent pulsation, presence of
ectatic vascular structures, and large drainage veins
[8, 20–22]. The recently developed power Doppler
ultrasound may provide more information on
shunts between hepatic arteries and veins and
better demonstration of dilated and tortuous hepatic
arteries [8].
In the present case, dilated communicating
venous channels between portal veins and the
hepatic vein were traced with real-time ultrasound
and demonstrated clearly with power Doppler
ultrasound. In patients with OWRD, the dilated
feeding hepatic artery in the hepato-duodenal liga-
ment and porta hepatis may mimic a dilated biliary
duct sonographically. Similarly, the dilated commu-
nicating venous channel can also be mistaken for
dilated intrahepatic bile ducts, the so-called “too
many tubes” sign. Color Doppler and/or power
Doppler ultrasound can portray color flow signals
in the dilated artery or venous channels. Power
Doppler is particularly good for delineation of the
vascular course in a more continuous fashion [8,
20]. However, in some vascular channels where the
vessels are extremely tortuous or intervening, there
may be difficulty in demonstrating the relationship
of the closely arranged vessels with color Doppler
and power Doppler ultrasound. Iodinated contrast
venography is the gold standard in this instance.
With the recent advent of USCA, it is possible to
introduce the contrast agent intravenously and to
observe the echo-enhancing effect in the target organs
or pathologies [23]. Levovist®, a galactose-based
contrast agent, can enter the portal vein via the
systemic circulation about 15 to 20 seconds after
intravenous administration. The vasculature of
hepatic tumors may be significantly enhanced with
intravenous USCA [24]. In this paper, we introduced
USCA directly into the right portal branch; the
portal branch, shunts, drainage hepatic veins and
inferior vena cava were enhanced with echogenic
microbubbles. Direct demonstration of the
communication enhances diagnostic confidence of
PHVS in some patients for whom noninvasive
imaging may not be conclusive. This minimally
invasive method can be safely monitored under
ultrasound guidance [25].
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